Screener
Regeneron Pharmaceuticals REGN Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's total debt?
- Regeneron Pharmaceuticals (REGN) reported total debt of $2.71B in Q2 2026.
- How has Regeneron Pharmaceuticals's total debt changed year-over-year?
- Regeneron Pharmaceuticals's total debt increased by 0.1% year-over-year, from $2.71B to $2.71B.
- What is the long-term trend for Regeneron Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's total debt has grown at a 2.0% compound annual growth rate (CAGR), from $2.7B to $2.97B.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Regeneron Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude